Surviving Pulmonary Hypertension: An Oral Alternative?
Castiller F, Trow T. Surviving Pulmonary Hypertension: An Oral Alternative? Clinical Pulmonary Medicine 2005, 12: 281-282. DOI: 10.1097/01.cpm.0000171504.71068.5a.Peer-Reviewed Original ResearchTreatment of pulmonary arterial hypertensionPrimary pulmonary hypertensionEndothelin receptor blockersPulmonary arterial hypertensionPulmonary hypertensionArterial hypertensionIntravenous alternativeOral alternativeReceptor blockersImproved survivalAdvanced hypertensionHypertensionBosentanSurvivalPatientsBlockersEndothelinTreating Human Immunodeficiency Virus–Associated Pulmonary Arterial Hypertension: Is Endothelin 1 a Target?
Trow T. Treating Human Immunodeficiency Virus–Associated Pulmonary Arterial Hypertension: Is Endothelin 1 a Target? Clinical Pulmonary Medicine 2005, 12: 196-197. DOI: 10.1097/01.cpm.0000163121.24487.48.Peer-Reviewed Original ResearchHuman immunodeficiency virus-associated pulmonary arterial hypertensionNew York Heart Association functional classPulmonary arterial hypertensionPulmonary hypertensionCardiopulmonary hemodynamicsQuality-of-life measuresArterial hypertensionEndothelin-1Treated patientsDrug interactionsSide effectsFunctional classBosentanWalking distanceHypertensionEndothelinPatientsHemodynamics